6C46.3

ICD-11 MMS 2026-01

Stimulant intoxication including amphetamines, methamphetamine or methcathinone

Description

Stimulant intoxication including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones is a clinically significant transient condition that develops during or shortly after the consumption of amphetamine or other stimulants that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of amphetamine or other stimulants and their intensity is closely related to the amount of amphetamine or other stimulant consumed. They are time-limited and abate as amphetamine or another stimulant is cleared from the body. Presenting features may include anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, paranoid ideation (possibly of delusional intensity), transient auditory hallucinations, transitory confusion, and changes in sociability. Perspiration or chills, nausea or vomiting, and palpitations may be experienced. Physical signs may include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and dystonias, and skin sores. In rare instances, usually in severe intoxication, use of stimulants including amphetamines, methamphetamine and methcathinone can result in seizures.

Index terms

  • Stimulant intoxication including amphetamines, methamphetamine or methcathinone
  • Amphetamine or certain specified stimulant intoxication
  • Amphetamine intoxication
Show allHide
  • Methamphetamine intoxication
  • Acute methamphetamine intoxication
  • acute methamphetamine toxicity

Excludes

  • 6B63 – Possession trance disorder
  • 6C45.3 – Cocaine intoxication
  • 6C47.3 – Synthetic cathinone intoxication
  • 6C48.2 – Caffeine intoxication
  • NE60 – amphetamine poisoning

Exclusions from above levels

  • 6C45 – Disorders due to use of cocaine
  • 6C47 – Disorders due to use of synthetic cathinones
  • 6C48 – Disorders due to use of caffeine
Show allHide
  • QE11.4 – Hazardous use of stimulants including amphetamines or methamphetamine
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C46.0 – Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
  • 6C46.1 – Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
  • 6C46.2 – Stimulant dependence including amphetamines, methamphetamine or methcathinone
  • 6C46.4 – Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
  • 6C46.5 – Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
  • 6C46.6 – Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
  • 6C46.7 – Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
  • 6C46.Y – Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
  • 6C46.Z – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified

Foundation entity

Stimulant intoxication including amphetamines, methamphetamine or methcathinone – http://id.who.int/icd/entity/1775535234

Allowed postcoordination axes

Part of: 6C46: Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone › 06: Mental, behavioural or neurodevelopmental disorders